Australia, March 17 -- Amgen Inc., owns the trademark (2610540) for 'CONFIPEN PRO' till Dec. 9, 2035.
Status: registered:
Registered/protected
Classes: 5 [Injectors for medical purposes pre-filled with pharmaceutical preparations for treating oncology, hematology, cardiovascular, metabolic and inflammatory diseases and conditions.], 10 [Injectors for medical purposes, namely, medical fluid injectors.], 5 [Injectors for medical purposes pre-filled with pharmaceutical preparations for treating oncology, hematology, cardiovascular, metabolic and inflammatory diseases and conditions] and 10 [Injectors for medical purposes, namely, medical fluid injectors]
Type of Mark: Word
Date of Acceptance: Jan. 6
Registration Advertised: March 16
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2610540.
Disclaimer: Curated by HT Syndication.
